NDC 51407-562 – Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate

Dextroamphetamine Sulfate 7.5 mg/1; Dextroamphetamine Saccharate 7.5 mg/1; Amphetamine Aspartate Monohydrate 7.5 mg/1; Amphetamine Sulfate 7.5 mg/1 · Capsule, Extended Release · Oral

Human Prescription Drug DEA schedule CII

Product NDC51407-562

Product details

Brand name
Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate
Generic name
Dextroamphetamine Sulfate, Dextroamphetamine Saccharate, Amphetamine Sulfate and Amphetamine Aspartate
Labeler
Golden State Medical Supply, Inc.
Dosage form
Capsule, Extended Release
Route
Oral
Marketing category
ANDA · ANDA214403
Marketed since
November 26, 2021
Listing expires
December 31, 2027
Pharmacologic class
Central Nervous System Stimulant; Central Nervous System Stimulant; Central Nervous System Stimulant; Central Nervous System Stimulant

Active ingredients

Uses, dosage, side effects and warnings for Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate →

Package NDC codes (1)

Package NDCDescriptionSince
51407-562-01100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (51407-562-01)Feb 21, 2023

Other Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate products